Thubrikar Aortic Valve Announces Authorization to Initiate Patient Implants Toward CE Mark Approval of Optimum TAV, and Development of Its Novel Precision 2 Delivery Catheter
With their transcatheter aortic valve now ready to enter clinical trials, Thubrikar Aortic Valve is offering hope to patients with aortic valve disease for significantly reduced trauma, complications and recovery
